SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $7,287,000 | -53.2% | 37,238 | -59.4% | 0.02% | -56.4% |
| Q2 2020 | $15,573,000 | +180.7% | 91,648 | +90.6% | 0.04% | +143.8% |
| Q1 2020 | $5,547,000 | -67.8% | 48,079 | -68.1% | 0.02% | -57.9% |
| Q4 2019 | $17,204,000 | +4357.0% | 150,569 | +1268.8% | 0.04% | +3700.0% |
| Q1 2016 | $386,000 | +192.4% | 11,000 | +193.8% | 0.00% | – |
| Q1 2015 | $132,000 | -99.1% | 3,744 | -99.2% | 0.00% | -100.0% |
| Q4 2014 | $14,360,000 | -48.7% | 446,950 | -40.6% | 0.04% | -51.1% |
| Q3 2014 | $27,965,000 | +2.1% | 752,150 | +5.0% | 0.09% | +4.7% |
| Q2 2014 | $27,392,000 | -24.3% | 716,150 | -9.8% | 0.09% | -28.9% |
| Q1 2014 | $36,176,000 | +13.7% | 794,023 | -0.5% | 0.12% | +10.0% |
| Q4 2013 | $31,828,000 | -28.2% | 797,888 | -21.1% | 0.11% | -35.7% |
| Q3 2013 | $44,334,000 | +9.1% | 1,011,482 | -21.7% | 0.17% | +6.2% |
| Q2 2013 | $40,653,000 | – | 1,292,227 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 50,060,240 | $5,775,950,000 | 35.57% |
| Lagoda Investment Management, L.P. | 72,969 | $8,419,000 | 9.97% |
| Avidity Partners Management LP | 580,000 | $66,920,000 | 9.25% |
| Arabesque Asset Management Ltd | 14,807 | $1,708,000 | 3.53% |
| Boxer Capital, LLC | 400,000 | $46,152,000 | 3.15% |
| Woodline Partners LP | 364,333 | $42,037,000 | 3.00% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 56,900 | $6,557,000 | 2.99% |
| SECTORAL ASSET MANAGEMENT INC | 107,000 | $12,346,000 | 2.37% |
| Capital International, Inc./CA/ | 1,197,659 | $138,186,000 | 2.33% |
| Bain Capital Public Equity Management II, LLC | 169,641 | $19,573,000 | 2.29% |